期刊文献+

非酒精性脂肪肝病小鼠模型的建立及评价 被引量:2

Establishment and evaluation of mouse models of nonalcoholic fatty liver disease
下载PDF
导出
摘要 目的运用饲料及药物进行3种不同的建模方式,造非酒精性脂肪肝病(NAFLD)小鼠模型,比较3种模型的特点,为NAFLD药物筛选提供实验基础。方法昆明鼠35只随机分成正常对照组(8只)、高脂饲料组(9只)、高糖高脂饲料组(9只)、高糖高脂饲料加氢化可的松组(9只)。实验4周后,观察各组小鼠体质量、活动情况、肝指数、血清生化指标、肝脏病理学等变化情况。结果相比正常对照组,高脂饲料组体质量增高最显著,高糖高脂饲料组次之,高糖高脂饲料加氢化可的松组体质量低于正常对照组(P<0.05);3种模型肝指数均高于正常组(P<0.05);血糖、血三酰甘油水平增高,肝脏三酰甘油显著高于正常对照组(P<0.05)。3组模型小鼠肝脏病理切片染色均出现肝脏脂肪变性,其中高糖高脂饲料加氢化可的松组肝脏脂肪变性最严重,为最优建模方法。结论不同处理方式都可制备NAFLD模型,但肝脏损伤程度不同。 Objective To establish and compare mouse models in order to evaluate drugs for nonalcoholic fatty liver disease (NAFLD) . Methods Thirty - five Kunming mice were divided intofour groups, namely, normal control group, high - fat diet group, high - fat and fructose diet group, high - fat and fructose plus hydrocortisone group. After four week treatment, the changes in mouse body weight, animal activity, liver index, serum biochemical indexes and liver pathology were detected and analyzed. Results Compared with normal control group, the weight increased most obviously in the high fat group, followed by high fat - fructose group, andthe weight of the high fat- fructose plus hydrocortisonewaslower thanthat of the normal control group (P 〈0. 05) . Andtheliver index in three models was higher thanthat of the normal control group(P 〈 0. 05). The serum glucose, triglyceride level, hepatic triglyceride were significantly higher than those in the normal control group ( P 〈 0. 05 ) . Among threemodels groups the histopathologic injury in mouse liver tissuesappeared the most serious on he-patic steatosis in the highfat - fructose plus hydrocortisone group,which was optimal method of established model. Conclusion NAFLD mod-el can be prepared by different treatment methods, but the degree of liver damage is different.
出处 《安徽医学》 2017年第7期823-826,共4页 Anhui Medical Journal
基金 国家自然科学基金项目(项目编号:81473461)
关键词 非酒精性脂肪肝病 高脂饮食 动物模型 Non - alcoholic fatty liver disease (NALFD) High fat diet Animal model
  • 相关文献

参考文献3

二级参考文献66

  • 1Yoshihisa Takahashi,Toshio Fukusato.Pediatric nonalcoholic fatty liver disease:Overview with emphasis on histology[J].World Journal of Gastroenterology,2010,16(42):5280-5285. 被引量:4
  • 2Fan, Jian-Gao,Qiao, Liang.Commonly used animal models of non-alcoholic steatohepatitis[J].Hepatobiliary & Pancreatic Diseases International,2009,8(3):233-240. 被引量:12
  • 3G Marchesini,M Brizi,G Bianchi,S Tomassetti,E Bugianesi,M Lenzi,AJ McCullough,S Natale,G Forlani,N Melchionda.Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes . 2001
  • 4G Pagano,G Pacini,G Musso,R Gambino,F Mecca,N Depetris,M Cassader.Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology . 2002
  • 5FAEH D,MINEHIRA K,SCHWARZ J M,et al.Effect offructose overfeeding and fish oil administration on hepaticde novo lipogenesis and insulin sensitivity in healthy men. Diabetes . 2005
  • 6Donnelly KL,Smith CI,Schwarzenberg SJ,et al.Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease〔J〕. The Journal of Clinical Investigation . 2005
  • 7Shinji Tamura,Iichiro Shimomura.Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease. The Journal of Clinical Investigation . 2005
  • 8H Herrema,M Meissner,TH Dijk.Bile salt sequestration induces hepatic de novo lipogenesis through farnesoid X receptor- and liver X receptor alpha-controlled metabolic pathways in mice. Hepatology . 2010
  • 9R Dhingra,L Sullivan,PF Jacques.Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation . 2007
  • 10Poonawala A,Nair SP,Thuluvath PJ.Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology . 2000

共引文献74

同被引文献12

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部